Small molecule-mediated induction of endoplasmic reticulum stress in cancer cells

Shalini Pandey1,2, Virender Kumar Sharma3, Ankur Biswas1

  • 1Department of Chemistry, Indian Institute of Science Education and Research (IISER)-Pune Homi Bhabha Road, Pashan Pune 411008 India ankur.biswas@students.iiserpune.ac.in.

RSC Medicinal Chemistry
|October 21, 2021
PubMed

Insights

Researchers developed a novel small molecule targeting the endoplasmic reticulum (ER) to induce cancer cell death. This molecule triggers ER stress and apoptosis, showing promise for new anticancer therapies.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Drug Discovery

Background:

  • The endoplasmic reticulum (ER) is vital for protein homeostasis and its dysfunction is linked to cancer.
  • Targeting the ER presents a novel strategy for cancer therapy, but selective small molecules are lacking.

Purpose of the Study:

  • To develop and evaluate novel small molecules for selective ER targeting in cancer therapy.
  • To investigate the mechanism of action of a novel ER-targeting small molecule.

Main Methods:

  • Synthesis of a sulfonylhydrazide-hydrazone small molecule library.
  • Fluorescent imaging to confirm ER localization in HeLa cells.
  • Assessment of ER stress, autophagy induction, and apoptosis in cancer cells.

Main Results:

  • A novel fluorescent small molecule was identified that localizes to the ER.
  • The molecule induced ER stress and triggered autophagy, which, when inhibited by chloroquine, led to apoptosis.
  • Significant cancer cell killing efficacy was observed in mono and combination therapy.

Conclusions:

  • The developed small molecule effectively targets the ER and induces cancer cell death.
  • This study opens a new avenue for ER-targeted anticancer drug development.

Related Concept Videos

Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
6.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.2K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
6.3K